Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
What's in Your Medicine Cabinet?
How many of us have medicine cabinets where we store our “you never know” items?
PC 360
Article
The Complex Landscape Surrounding High-Impact Drugs & Workers' Comp
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for pot
Mitchell
News Release
Mitchell Awarded Third Patent for Collision Repair Diagnostics
Company continues to add to its growing portfolio of issued U.S.
Risk & Insurance
In the News
P&C Update: Auto Liability and Workers’ Comp Could See a Tidal Wave of Change in 2023
mitchell
News Release
Mitchell Diagnostics Reaches New Milestone for Dynamic and Static Calibrations
Latest achievement driven by increasing vehicle complexity and growing reliance on the company's ADAS calibration target system
Business Insurance
In the News